• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.

作者信息

McGovern Andrew P, Thomas Nick J, Vollmer Sebastian J, Hattersley Andrew T, Mateen Bilal A, Dennis John M

机构信息

Institute of Biomedical & Clinical Science, University of Exeter Medical School, Royal Devon & Exeter Hospital, Exeter, UK.

Diabetes and Endocrinology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

出版信息

Diabetologia. 2021 May;64(5):1184-1186. doi: 10.1007/s00125-021-05404-8. Epub 2021 Feb 16.

DOI:10.1007/s00125-021-05404-8
PMID:33594475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7885981/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/240c/8012316/0d71d3be5dec/125_2021_5404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/240c/8012316/0d71d3be5dec/125_2021_5404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/240c/8012316/0d71d3be5dec/125_2021_5404_Fig1_HTML.jpg

相似文献

1
The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.糖尿病青年人群中新冠病毒肺炎（COVID-19）不成比例的过高死亡风险，使得疫苗接种优先排序成为必要。
Diabetologia. 2021 May;64(5):1184-1186. doi: 10.1007/s00125-021-05404-8. Epub 2021 Feb 16.
2
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
3
Trend in COVID-19 vaccination among people with diabetes: A short study from India.糖尿病患者中新冠病毒疫苗接种趋势：来自印度的一项简短研究。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102190. doi: 10.1016/j.dsx.2021.102190. Epub 2021 Jun 29.
4
Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.未接种疫苗及相关合并症使感染德尔塔变异株的个体更易需要重症监护——来自印度新德里一家三级护理医院的病例队列研究
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102203. doi: 10.1016/j.dsx.2021.102203. Epub 2021 Jul 9.
5
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.COVID-19 住院、死亡、疫苗接种和以色列精神分裂症患者的疫苗接种后趋势：一项纵向队列研究。
Lancet Psychiatry. 2021 Oct;8(10):901-908. doi: 10.1016/S2215-0366(21)00256-X. Epub 2021 Aug 6.
6
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.糖尿病对 COVID-19 相关住院死亡率的影响：来自意大利北部的回顾性研究。
J Endocrinol Invest. 2021 Apr;44(4):843-850. doi: 10.1007/s40618-020-01382-7. Epub 2020 Aug 10.
7
[Vaccination immunology in SARS-CoV-2].[新型冠状病毒肺炎中的疫苗接种免疫学]
Ugeskr Laeger. 2021 Mar 15;183(11).
8
India begins COVID-19 vaccination amid trial allegations.印度在面临试验指控的情况下开始新冠疫苗接种。
Lancet. 2021 Jan 23;397(10271):264. doi: 10.1016/S0140-6736(21)00145-8.
9
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.炎症性风湿病患者接种 SARS-CoV-2 疫苗：疫苗广泛可用前的考虑因素。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2020-001553.
10
COVID-19 vaccination among socially vulnerable people who use drugs.在使用毒品的社会弱势群体中接种新冠病毒疫苗。
Addiction. 2021 Sep;116(9):2590-2591. doi: 10.1111/add.15500. Epub 2021 May 3.

引用本文的文献

1
COVID-19 Vaccine Effectiveness and Risk Factors of Booster Failure in 480,000 Patients with Diabetes Mellitus: A Population-Based Cohort Study.48万糖尿病患者中COVID-19疫苗效力及加强针接种失败的风险因素：一项基于人群的队列研究
Microorganisms. 2025 Apr 24;13(5):979. doi: 10.3390/microorganisms13050979.
2
COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters.糖尿病患者中COVID-19疫苗接种反应及突破性感染风险：基于社区报告者的队列研究
JMIR Diabetes. 2024 Feb 27;9:e45536. doi: 10.2196/45536.
3
Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States.

本文引用的文献

1
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.患有糖尿病的人感染 COVID-19 疾病的风险和风险因素：苏格兰全人群的队列研究。
Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. doi: 10.1016/S2213-8587(20)30405-8. Epub 2020 Dec 23.
2
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.成人因冠状病毒 19 住院和死亡风险的生存风险预测算法（QCOVID）：全国推导和验证队列研究。
BMJ. 2020 Oct 20;371:m3731. doi: 10.1136/bmj.m3731.
3
Use of "normal" risk to improve understanding of dangers of covid-19.
美国新冠疫情期间与糖尿病相关的额外死亡病例。
EClinicalMedicine. 2022 Dec;54:101671. doi: 10.1016/j.eclinm.2022.101671. Epub 2022 Sep 23.
4
Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry.肥胖与代谢健康受损使中青年成年人新冠相关死亡风险增至老年人水平：LEOSS注册研究
Front Med (Lausanne). 2022 May 11;9:875430. doi: 10.3389/fmed.2022.875430. eCollection 2022.
5
COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study.秘鲁北部一家转诊医院的新冠疫苗有效性：一项回顾性队列研究。
Vaccines (Basel). 2022 May 20;10(5):812. doi: 10.3390/vaccines10050812.
6
COVID-19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects.青少年和年轻成年 1 型糖尿病患者的 COVID-19 疫苗接种：血糖控制和副作用。
Pediatr Diabetes. 2022 Jun;23(4):469-472. doi: 10.1111/pedi.13326. Epub 2022 Mar 2.
7
Smoking is significantly associated with increased risk of COVID-19 and other respiratory infections.吸烟与 COVID-19 和其他呼吸道感染的风险增加显著相关。
Commun Biol. 2021 Oct 28;4(1):1230. doi: 10.1038/s42003-021-02685-y.
8
COVID-19 and metabolic disease: mechanisms and clinical management.新型冠状病毒肺炎与代谢性疾病：机制与临床管理。
Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798. doi: 10.1016/S2213-8587(21)00244-8. Epub 2021 Oct 4.
9
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).心血管疾病与 COVID-19：ESC 冠状动脉病理生理学和微循环工作组、ESC 血栓形成工作组以及急性心血管护理协会（ACVC）与欧洲心律协会（EHRA）合作的共识文件。
Cardiovasc Res. 2021 Dec 17;117(14):2705-2729. doi: 10.1093/cvr/cvab298.
10
Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome.基于肝代谢物的间歇性禁食可使 2 型糖尿病和代谢综合征的胰岛素抵抗持续降低。
Horm Metab Res. 2021 Aug;53(8):529-540. doi: 10.1055/a-1510-8896. Epub 2021 Jun 30.
使用“正常”风险来增进对新冠病毒19危险的理解。
BMJ. 2020 Sep 9;370:m3259. doi: 10.1136/bmj.m3259.
4
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.1 型和 2 型糖尿病与英格兰 COVID-19 相关死亡率的关联：一项全人群研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2. Epub 2020 Aug 13.
5
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素：一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
6
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
7
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.COVID-19 合并糖尿病住院患者的表型特征和预后：CORONADO 研究。
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
8
How old are you, really? Communicating chronic risk through 'effective age' of your body and organs.你究竟多大了？通过身体和器官的“有效年龄”来传达慢性风险。
BMC Med Inform Decis Mak. 2016 Aug 5;16:104. doi: 10.1186/s12911-016-0342-z.